NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of Feb. 1
Atotech – Berlin, Germany, 34.1 million shares, priced $19-$22, managed by Citi/Credit Suisse. Proposed NYSE ATC. Business: Carlye-backed specialty chemicals company carved out of Total.
Evaxion Biotech – Copenhagen, Denmark, 2.8 million shares, priced $10-$12, managed by Oppenheimer & Co/Ladenburg Thalmann. Proposed Nasdaq symbol EVAX. Business: Danish Phase 1/2 biotech using AI to develop immuno-ocology therapies.
Landos Biopharma – Blacksburg, Va., 6.3 million shares, priced $15-$17, managed by JP Morgan Stanley/Jefferies. Proposed Nasdaq symbol LABP. Business: Phase 2 biotech developing oral small molecule therapies for autoimmune diseases.
loanDepot – Foothill Ranch, Calif., 15 million shares, priced $19-$21, managed by Goldman Sachs/BofA Securities. Proposed NYSE LDI. Business: Nonbank lender focused on mortgages and unsecured personal loans.
ON24 – San Francisco, 8.6 million shares, priced $45-$50, managed by Goldman Sachs/JP Morgan. Proposed NYSE ONTF. Business: Provides cloud-based webcasting and virtual communications services.
Sana Biotechnology – Seattle, 15 million shares, priced $20-$22, managed by Morgan Stanley/Goldman Sachs. Proposed Nasdaq symbol SANA. Business: Preclinical biotech developing engineered cell therapies for multiple indications.
TELUS International – Vancouver, Canada, 33.3 million shares, priced $23-$25, managed by JP Morgan/Morgan Stanley. Proposed NYSE symbol TIXT. Business: Provides customers service outsourcing and digital IT services.
urban-gro – Lafayette, Colo., 4.3 million shares, priced at $10.50, managed by ThinkEquity. Proposed Nasdaq symbol UGRO. Business: Provides equipment and services for the commercial indoor horticulture market.
The Associated Press